Prevalence of Delirium in Outpatient Clinics

Sponsor
Gulhane Training and Research Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04973709
Collaborator
(none)
714
1
15.2
46.9

Study Details

Study Description

Brief Summary

The aim of this study is to assess the prevalence and etiologic risk factors of delirium in outpatient geriatric patients and also hospitalized patients.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Confussion assessment method (CAM)
  • Diagnostic Test: Dementia diagnosis

Detailed Description

This study aimed to investigate the frequency of delirium and examines the association between delirium and other possible risk factors and prognostic factors (dementia etc.)

Study Design

Study Type:
Observational
Anticipated Enrollment :
714 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Gulhane Training and Research Hospital
Anticipated Study Start Date :
Aug 5, 2021
Anticipated Primary Completion Date :
Oct 5, 2021
Anticipated Study Completion Date :
Nov 11, 2022

Arms and Interventions

Arm Intervention/Treatment
Delirium with dementia

Delirium was detected using the short form of the Confusion Assessment Method (CAM) both at admission and daily throughout the hospital stay. Cognitive status was determined using the Mini-Mental State Exam, Clinical Dementia Rating (CDR). Dementia was defined by a CDR score of 1. The primary independent variable was a composite of delirium and dementia diagnosis, and we examined the overlap by categorizing the cases into four groups: no delirium or dementia, dementia alone, delirium alone, and DSD.

Diagnostic Test: Confussion assessment method (CAM)
Participants enrolled in the Delirium group according to the CAM.

Diagnostic Test: Dementia diagnosis
Participants enrolled in the Dementia group according to the CDR scores and MMSE scores and DSM4/5 criteria

Dementia without Delirium

Delirium was detected using the short form of the Confusion Assessment Method (CAM) both at admission and daily throughout the hospital stay. Cognitive status was determined using the Mini-Mental State Exam, Clinical Dementia Rating (CDR). Dementia was defined by a CDR score of 1. The primary independent variable was a composite of delirium and dementia diagnosis, and we examined the overlap by categorizing the cases into four groups: no delirium or dementia, dementia alone, delirium alone, and DSD.

Diagnostic Test: Dementia diagnosis
Participants enrolled in the Dementia group according to the CDR scores and MMSE scores and DSM4/5 criteria

Delirium without Dementia

Delirium was detected using the short form of the Confusion Assessment Method (CAM) both at admission and daily throughout the hospital stay. Cognitive status was determined using the Mini-Mental State Exam, Clinical Dementia Rating (CDR). Dementia was defined by a CDR score of 1. The primary independent variable was a composite of delirium and dementia diagnosis, and we examined the overlap by categorizing the cases into four groups: no delirium or dementia, dementia alone, delirium alone, and DSD.

Diagnostic Test: Confussion assessment method (CAM)
Participants enrolled in the Delirium group according to the CAM.

No dementia, No delirium

Delirium was detected using the short form of the Confusion Assessment Method (CAM) both at admission and daily throughout the hospital stay. Cognitive status was determined using the Mini-Mental State Exam, Clinical Dementia Rating (CDR). Dementia was defined by a CDR score of 1. The primary independent variable was a composite of delirium and dementia diagnosis, and we examined the overlap by categorizing the cases into four groups: no delirium or dementia, dementia alone, delirium alone, and DSD.

Outcome Measures

Primary Outcome Measures

  1. frequency of Mortality [1 year fellow-up]

    1st year mortality according to the electronic national data base

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • We included all 65 years older patients who evaluated according to a comprehensive geriatric assessment that is consistently performed during admission to the outpatients' clinic of the hospital.
Exclusion Criteria:
  • Exclusion criteria were serious psychiatric disorders such as schizophrenia or major depression.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Gulhane training and research hospital Ankara Turkey 06670

Sponsors and Collaborators

  • Gulhane Training and Research Hospital

Investigators

  • Principal Investigator: Mehmet Naharcı, Saglik Bilimleri Universitesi

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bilal Katipoglu, Principal investigator, Gulhane Training and Research Hospital
ClinicalTrials.gov Identifier:
NCT04973709
Other Study ID Numbers:
  • 2020-382
First Posted:
Jul 22, 2021
Last Update Posted:
Jul 22, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Keywords provided by Bilal Katipoglu, Principal investigator, Gulhane Training and Research Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 22, 2021